mean inhibitory concentration (mic) standards Search Results


90
Clinical and Laboratory Standards Institute minimum inhibitory concentration (mic) by broth microdilution
Minimum Inhibitory Concentration (Mic) By Broth Microdilution, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/minimum+inhibitory+concentration++mic++of+znnps/10__2807_slash_1560___7917__es__2018__23__6__17___00672-41-7-30
Average 90 stars, based on 1 article reviews
minimum inhibitory concentration (mic) by broth microdilution - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute mic (minimal inhibitory concentration)
Mic (Minimal Inhibitory Concentration), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/mic+minimum+inhibitory+concentration/pmc04234847-64-18-30
Average 90 stars, based on 1 article reviews
mic (minimal inhibitory concentration) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute minimum inhibitory concentrations (mics)
Minimum Inhibitory Concentrations (Mics), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/minimum+inhibitory+concentration++mic+/us09187495-2014-2-20
Average 90 stars, based on 1 article reviews
minimum inhibitory concentrations (mics) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute mean inhibitory concentration (mic) standards
Mean Inhibitory Concentration (Mic) Standards, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/mean+inhibitory+concentration++mic++standards/pmc08881957-87-10-3
Average 90 stars, based on 1 article reviews
mean inhibitory concentration (mic) standards - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute vancomycin minimum inhibitory concentrations (mics)
Vancomycin Minimum Inhibitory Concentrations (Mics), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/vancomycin+minimum+inhibitory+concentration++mic+/pmc03526863-38-8-44
Average 90 stars, based on 1 article reviews
vancomycin minimum inhibitory concentrations (mics) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute broth microdilution minimum inhibitory concentrations (mics) method
Broth Microdilution Minimum Inhibitory Concentrations (Mics) Method, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/broth+microdilution+minimum+inhibitory+concentration++mic++testing/pmc08579135-104-10-20
Average 90 stars, based on 1 article reviews
broth microdilution minimum inhibitory concentrations (mics) method - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute tobramycin minimal inhibitory concentration (mic)
Tobramycin Minimal Inhibitory Concentration (Mic), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/tobramycin+minimal+inhibitory+concentration++mic+/10__1128_slash_aac__01166___20-77-15-25
Average 90 stars, based on 1 article reviews
tobramycin minimal inhibitory concentration (mic) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute disc-diffusion minimal inhibitory concentration (mic) breakpoints for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin
Calculated by applying the Clinical and Laboratory Standards Institute (CLSI) break-point values for trimethoprim-sulfamethoxazole, minocycline, and <t>levofloxacin;</t> and broth dilution MIC breakpoints for ceftazidime. There are no MIC interpretive criteria for tigecycline, colistin, or aztreonam, so susceptibility to them is assumed using interpretive criteria for Enterobacteriaceae. European Committee on Antimicrobial Susceptibility Testing (EUCAST) has only published breakpoint criteria for trimethoprim-sulfamethoxazole. Total number of samples, n = 317
Disc Diffusion Minimal Inhibitory Concentration (Mic) Breakpoints For Trimethoprim Sulfamethoxazole, Minocycline, And Levofloxacin, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/disc+diffusion+minimal+inhibitory+concentration++mic++breakpoints+for+trimethoprim+sulfamethoxazole++minocycline++and+levofloxacin/pmc09013242-59-20-2
Average 90 stars, based on 1 article reviews
disc-diffusion minimal inhibitory concentration (mic) breakpoints for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute liquid media assay minimum inhibitory concentration (mic)
Calculated by applying the Clinical and Laboratory Standards Institute (CLSI) break-point values for trimethoprim-sulfamethoxazole, minocycline, and <t>levofloxacin;</t> and broth dilution MIC breakpoints for ceftazidime. There are no MIC interpretive criteria for tigecycline, colistin, or aztreonam, so susceptibility to them is assumed using interpretive criteria for Enterobacteriaceae. European Committee on Antimicrobial Susceptibility Testing (EUCAST) has only published breakpoint criteria for trimethoprim-sulfamethoxazole. Total number of samples, n = 317
Liquid Media Assay Minimum Inhibitory Concentration (Mic), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/liquid+media+assay+minimum+inhibitory+concentration++mic+/us08399033-163-5-21
Average 90 stars, based on 1 article reviews
liquid media assay minimum inhibitory concentration (mic) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute fluconazole minimum inhibitory concentration (mic)
Deletion of CST6 reduces <t>fluconazole</t> hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.
Fluconazole Minimum Inhibitory Concentration (Mic), supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/fluconazole+minimum+inhibitory+concentration++mic+/pmc11823675-37-21-33
Average 90 stars, based on 1 article reviews
fluconazole minimum inhibitory concentration (mic) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute 2017 minimum inhibitory concentration (mic) breakpoint criterion
Deletion of CST6 reduces <t>fluconazole</t> hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.
2017 Minimum Inhibitory Concentration (Mic) Breakpoint Criterion, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/2017+minimum+inhibitory+concentration++mic++breakpoint+criterion/pm29960008-43-5-14
Average 90 stars, based on 1 article reviews
2017 minimum inhibitory concentration (mic) breakpoint criterion - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute vcm minimum inhibitory concentration (mic) susceptibility breakpoint
Forest plots of all-cause mortality and treatment success rates for patients treated with DAP versus <t>VCM</t> for bacteremia caused by MRSA with VCM <t>MIC</t> > 1 µg/mL. ( A , B ) Forest plots of the all-cause mortality rate ( A ) and treatment success rate ( B ) of patients treated with DAP versus VCM in the studies evaluated. The vertical line indicates no significant difference between the groups compared. Diamonds and horizontal lines represent the Mantel–Haenszel ORs and 95% CIs, respectively. Squares indicate point estimates, and the size of the square indicates the weight of each study included in the meta-analysis. CI, confidence interval; DAP, daptomycin; MIC, minimum <t>inhibitory</t> concentration; MRSA, methicillin-resistant Staphylococcus aureus ; OR, odds ratio; VCM, vancomycin.
Vcm Minimum Inhibitory Concentration (Mic) Susceptibility Breakpoint, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+inhibitory+concentration+(mic)+standards/vcm+minimum+inhibitory+concentration++mic++susceptibility+breakpoint/pmc09032134-18-8-1
Average 90 stars, based on 1 article reviews
vcm minimum inhibitory concentration (mic) susceptibility breakpoint - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Calculated by applying the Clinical and Laboratory Standards Institute (CLSI) break-point values for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin; and broth dilution MIC breakpoints for ceftazidime. There are no MIC interpretive criteria for tigecycline, colistin, or aztreonam, so susceptibility to them is assumed using interpretive criteria for Enterobacteriaceae. European Committee on Antimicrobial Susceptibility Testing (EUCAST) has only published breakpoint criteria for trimethoprim-sulfamethoxazole. Total number of samples, n = 317

Journal: Cureus

Article Title: Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study

doi: 10.7759/cureus.23263

Figure Lengend Snippet: Calculated by applying the Clinical and Laboratory Standards Institute (CLSI) break-point values for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin; and broth dilution MIC breakpoints for ceftazidime. There are no MIC interpretive criteria for tigecycline, colistin, or aztreonam, so susceptibility to them is assumed using interpretive criteria for Enterobacteriaceae. European Committee on Antimicrobial Susceptibility Testing (EUCAST) has only published breakpoint criteria for trimethoprim-sulfamethoxazole. Total number of samples, n = 317

Article Snippet: The US Clinical and Laboratory Standards Institute (CSLI) has published disc-diffusion minimal inhibitory concentration (MIC) breakpoints for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin and broth dilution MIC breakpoints for ticarcillin-clavulanic acid, ceftazidime, minocycline, levofloxacin, and chloramphenicol [ ].

Techniques:

Deletion of CST6 reduces fluconazole hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Deletion of CST6 reduces fluconazole hyper-susceptibility of upc2A ∆ mutants. (A) Location of CST6 mutations in evolved strains isolated reported in reference and schematic of Cst6 protein showing position relative to the DNA-binding domain (DBD). (B) A dilution series of the indicated strains were spotted on YPD and YPD with the indicated amount of fluconazole. The plates were incubated for 48 h prior to imaging. The phenotypes are representative of three biological replicates. (C) The indicated strains were plated on YPD medium and incubated in ambient air (normoxia) or in a GAS PAK (hypoxia). (D) Biofilms were generated in RPMI buffered with 0.165 M morpholino-propanesulfonic acid (MOPS) for 72 h before treatment with sham or 1000 µg/mL fluconazole. The wells were incubated for an additional 24 h, and biofilm formation was assayed by metabolic activity as described in Materials and Methods. Bars indicate mean of absorption of the XTT assay, with error bars indicating standard deviation. Asterisks indicate statistically significant differences by one-way analysis of variance followed by Tukey’s correction for multiple comparisons; *<0.05; **<0.01; ***<0.001.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Isolation, Binding Assay, Incubation, Imaging, Generated, Activity Assay, XTT Assay, Standard Deviation

Deletion of CST6 does not increase ergosterol levels, ERG gene expression or CDR1 efflux pump expression in the presence of fluconazole. (A) The ergosterol content of the indicated strains in the presence of fluconazole (16 µg/mL) was determined as described in Materials and Methods. Bars indicate mean and error bars indicate standard deviation for three biological replicates. * indicates statistically significant difference ( P < 0.05) from WT by one-way analysis of variance (ANOVA) and Tukey’s correction for multiple comparisons. The percentage of (B) lanosterol and (C) 14 methyl ergosta-8,24 (28)-dien-3–6-diol (14-MEDD) relative to total sterols in the indicated strains was determined as described in Materials and Methods in the presence of fluconazole (µg/mL). Full data set provided in . (D) The expression of the indicated genes relative for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT were determined in the presence of fluconazole (16 µg/mL) by qRT-PCR. The fold change is relative WT, and * indicates statistically significant ( P < 0.05) difference by one-way ANOVA and Tukey’s correction for multiple comparisons. Bars indicate mean of three biological replicates performed in technical triplicate, with error bars indicating standard deviation.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Deletion of CST6 does not increase ergosterol levels, ERG gene expression or CDR1 efflux pump expression in the presence of fluconazole. (A) The ergosterol content of the indicated strains in the presence of fluconazole (16 µg/mL) was determined as described in Materials and Methods. Bars indicate mean and error bars indicate standard deviation for three biological replicates. * indicates statistically significant difference ( P < 0.05) from WT by one-way analysis of variance (ANOVA) and Tukey’s correction for multiple comparisons. The percentage of (B) lanosterol and (C) 14 methyl ergosta-8,24 (28)-dien-3–6-diol (14-MEDD) relative to total sterols in the indicated strains was determined as described in Materials and Methods in the presence of fluconazole (µg/mL). Full data set provided in . (D) The expression of the indicated genes relative for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT were determined in the presence of fluconazole (16 µg/mL) by qRT-PCR. The fold change is relative WT, and * indicates statistically significant ( P < 0.05) difference by one-way ANOVA and Tukey’s correction for multiple comparisons. Bars indicate mean of three biological replicates performed in technical triplicate, with error bars indicating standard deviation.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Gene Expression, Expressing, Standard Deviation, Quantitative RT-PCR

Effect of the cst6 ∆ upc2A ∆ mutant on gene expression relative to single mutants in the presence of fluconazole. (A) Heatmap comparing the expression (RNA-seq) of the indicated ERG genes and the adhesin EPA3 for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT (BG2). Biological process GO term analysis of genes downregulated in the upc2A ∆ cst6 ∆ (B) and upc2A ∆ (C) mutants in the presence of fluconazole with the number of genes in each GO term group listed on the x-axis. The FDR was determined by Benjamini-Hochberg analysis. (D) Representative mitochondrial and respiration genes downregulated in the upc2A ∆ mutant is shown.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Effect of the cst6 ∆ upc2A ∆ mutant on gene expression relative to single mutants in the presence of fluconazole. (A) Heatmap comparing the expression (RNA-seq) of the indicated ERG genes and the adhesin EPA3 for the upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants relative to WT (BG2). Biological process GO term analysis of genes downregulated in the upc2A ∆ cst6 ∆ (B) and upc2A ∆ (C) mutants in the presence of fluconazole with the number of genes in each GO term group listed on the x-axis. The FDR was determined by Benjamini-Hochberg analysis. (D) Representative mitochondrial and respiration genes downregulated in the upc2A ∆ mutant is shown.

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Mutagenesis, Gene Expression, Expressing, RNA Sequencing

Forced respiration with glycerol medium increases fluconazole susceptibility of cst6 ∆, upc2A ∆, and upc2A ∆ cst6 ∆ mutants. (A) The upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants were plated on YP + 2% glucose and YP + 2% glycerol medium and incubated at 30°C or 37°C for 48–72 h. (B) The minimum inhibitory concentration (MIC) of fluconazole was determined after incubation for 24 h (glucose) or 48 h (glycerol) at 37°C. (C) The effect of loss of Upc2A function on the expression of ERG genes in the cst6 ∆ mutant by RNA-seq. Full data set is in . All changes were statistically significant (adjusted P < 0.05).

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility

doi: 10.1128/aac.01294-24

Figure Lengend Snippet: Forced respiration with glycerol medium increases fluconazole susceptibility of cst6 ∆, upc2A ∆, and upc2A ∆ cst6 ∆ mutants. (A) The upc2 A∆, cst6 ∆, and upc2A ∆ cst6 ∆ mutants were plated on YP + 2% glucose and YP + 2% glycerol medium and incubated at 30°C or 37°C for 48–72 h. (B) The minimum inhibitory concentration (MIC) of fluconazole was determined after incubation for 24 h (glucose) or 48 h (glycerol) at 37°C. (C) The effect of loss of Upc2A function on the expression of ERG genes in the cst6 ∆ mutant by RNA-seq. Full data set is in . All changes were statistically significant (adjusted P < 0.05).

Article Snippet: The decreased susceptibility of the cst6 ∆ mutant on spot dilution assays is consistent with our previously reported observation that its fluconazole minimum inhibitory concentration (MIC) is fourfold increased relative to WT under Clinical and Laboratory Standards Institute (CLSI) conditions ( ).

Techniques: Incubation, Concentration Assay, Expressing, Mutagenesis, RNA Sequencing

Forest plots of all-cause mortality and treatment success rates for patients treated with DAP versus VCM for bacteremia caused by MRSA with VCM MIC > 1 µg/mL. ( A , B ) Forest plots of the all-cause mortality rate ( A ) and treatment success rate ( B ) of patients treated with DAP versus VCM in the studies evaluated. The vertical line indicates no significant difference between the groups compared. Diamonds and horizontal lines represent the Mantel–Haenszel ORs and 95% CIs, respectively. Squares indicate point estimates, and the size of the square indicates the weight of each study included in the meta-analysis. CI, confidence interval; DAP, daptomycin; MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus ; OR, odds ratio; VCM, vancomycin.

Journal: Pharmaceutics

Article Title: Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis

doi: 10.3390/pharmaceutics14040714

Figure Lengend Snippet: Forest plots of all-cause mortality and treatment success rates for patients treated with DAP versus VCM for bacteremia caused by MRSA with VCM MIC > 1 µg/mL. ( A , B ) Forest plots of the all-cause mortality rate ( A ) and treatment success rate ( B ) of patients treated with DAP versus VCM in the studies evaluated. The vertical line indicates no significant difference between the groups compared. Diamonds and horizontal lines represent the Mantel–Haenszel ORs and 95% CIs, respectively. Squares indicate point estimates, and the size of the square indicates the weight of each study included in the meta-analysis. CI, confidence interval; DAP, daptomycin; MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus ; OR, odds ratio; VCM, vancomycin.

Article Snippet: The Clinical and Laboratory Standards Institute established the VCM minimum inhibitory concentration (MIC) susceptibility breakpoint as 2 μg/mL for S. aureus while the definitions of vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus were MICs of 4 to 8 μg/mL and ≥16 μg/mL, respectively [ ].

Techniques: Concentration Assay